Stock SPHDF SANTHERA PHARMACEUTICALS HOLDING AG
Add to a list
To use this feature you must be a member
Log inSign up

Company Santhera Pharmaceuticals Holding AG OTC Markets

Equities

SPHDF

CH1276028821

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 10:53:09 22/02/2024 pm IST 		5-day change 1st Jan Change
11.7 USD +4.00% Intraday chart for Santhera Pharmaceuticals Holding AG -.--% -.--%
19/06 Transcript : Santhera Pharmaceuticals Holding AG - Special Call
18/06 Santhera Secures CHF69 Million Financing for Bond Repayment, Cash Runway Extension MT

Business Summary

Santhera Pharmaceuticals Holding AG (Santhera) is a Switzerland-based company engaged in the pharmaceutical sector. The Company operates through one business segment, which is the research, development and commercialization of pharmaceutical products for the treatment of neuromuscular and mitochondrial diseases, such as Duchenne muscular dystrophy (DMD) and cystic fibrosis (CF). The Company focuses also on development of gene therapy for the treatment of LAMA2 (Laminin Subunit Alpha 2) deficient congenital muscular dystrophy (CMD). Santhera operates through its wholly owned subsidiaries: Santhera Pharmaceuticals (Schweiz) AG, Liestal, Santhera Pharmaceuticals (USA) Inc, Santhera Pharmaceuticals (Canada) Inc, Santhera Pharmaceutical (Deutschland) GmbH and Oy Santhera Pharmaceuticals (Finland) Ltd.

Number of employees: 45

Sales per Business

CHF in Million2022Weight2023Weight Delta
Specialty Niche Products
100.0 %
7 100.0 % 103 100.0 % +1,283.84%

Sales per region

CHF in Million2022Weight2023Weight Delta
North America
94.9 %
-- 98 94.9 % -
Europe
3.3 %
-4 -49.7 % 3 3.3 % -191.53%
Asia
1.9 %
11 149.7 % 2 1.9 % -82.83%

Managers

Managers TitleAgeSince
Dario Eklund CEO
 Chief Executive Officer 56 01/19/01
Thomas Meier FOU
 Founder 62 07/04/07
Andrew Smith DFI
 Director of Finance/CFO 61 01/20/01
Marc Schrader CTO
 Chief Tech/Sci/R&D Officer - 01/22/01
Shabir Hasham CTO
 Chief Tech/Sci/R&D Officer - 01/15/01
Sarah Holmes-Klotz HRO
 Human Resources Officer - 01/22/01
Andreas Missy HRO
 Human Resources Officer - 01/20/01
Neville Kodkani SAM
 Sales & Marketing - 01/15/01
Oliver Strub LAW
 General Counsel 61 01/06/01
Günther Metz PRN
 Corporate Officer/Principal 66 01/04/01

Members of the board

Members of the board TitleAgeSince
Thomas Meier FOU
 Founder 62 07/04/07
Philipp Gutzwiller BRD
 Director/Board Member 56 04/17/04
Otto Schwarz BRD
 Director/Board Member 68 27/23/27
Bradley Meyer BRD
 Director/Board Member - 27/23/27

Shareholders

NameEquities%Valuation
SANTHERA PHARMACEUTICALS HOLDING AG
15.85 %
2,001,327 15.85 % 22 M $
CATALYST PHARMACEUTICALS, INC.
11.21 %
1,414,688 11.21 % 15 M $
IDORSIA LTD
10.31 %
1,301,128 10.31 % 14 M $
Thomas Meier
0.0246 %
3,108 0.0246 % 34 003 $
CATAM Asset Management AG
0.0238 %
3,000 0.0238 % 32 822 $
Philipp Gutzwiller
0.0107 %
1,350 0.0107 % 14 770 $
Dario Eklund
0.003564 %
450 0.003564 % 4 923 $
DWS CH AG
0.003168 %
400 0.003168 % 4 376 $
Bradley Meyer
0.002455 %
310 0.002455 % 3 392 $
Shabir Hasham
0.002099 %
265 0.002099 % 2 899 $

Holdings

NameEquities%Valuation
SANTHERA PHARMACEUTICALS HOLDING AG
15.85%
 2,001,327 15.85% 21,895,578 $

Company contact information

Santhera Pharmaceuticals Holding AG

Hohenrainstrasse 24

4133, Pratteln

+41 61 906 89 50

http://www.santhera.com
address Santhera Pharmaceuticals Holding AG(SPHDF)

Group companies

NameCategory and Sector
Santhera Pharmaceuticals (Switzerland) Ltd.

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
8.3 CHF
Average target price
34.5 CHF
Spread / Average Target
+315.66%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
MERCK KGAA Stock Merck KGaA
+4.96% 7TCr
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+16.65% 905.03Cr
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-22.81% 443.12Cr
YUHAN CORPORATION Stock Yuhan Corporation
+14.83% 415.89Cr
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+19.21% 383.31Cr
INDIVIOR PLC Stock Indivior PLC
-1.86% 205.72Cr
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+8.78% 202.15Cr
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-36.94% 189.87Cr
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-45.25% 170.95Cr
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SANN Stock
  4. SPHDF Stock
  5. Company Santhera Pharmaceuticals Holding AG